Abstract
Background:
In the present study, a novel tissue engineering bone graft including platelet rich plasma gel (PRP gel), human umbilical mesenchymal stem cells (HUMSCs) and nanohydroxyapatite/polyamide 66 (nHA-PA66) was constructed. We explored whether the composite scaffolds could enhance the angiogenesis and bone repair capacity in rat femoral large bone defect (LBD). This study aimed to provide evidence for the clinical application of the composite scaffold in LBD treatment.
Methods:
PRP was prepared, the platelets and growth factors were measured. HUMSCs were isolated and identified. the osteogenic capacity of PRP in vitro was measured. Then HUMSCs-PRP-gel/nHA-PA66 composite scaffolds were synthesized and observed. The proliferation and osteogenesis differentiation of HUMSCs on the composite scaffold was measured. The angiogenic capacity of PRP in vitro was measured by capillary-like tube formation assay. Finally, the angiogenesis and bone repair capacity of the composite scaffolds was measured in rat LBD.
Results:
PRP contained high level of platelets and growth factors after activation, and promoted osteogenic and angiogenic differentiation in vitro. The HUMSCs-PRP-gel/nHA-PA66 composite scaffold was porosity and promoted the proliferation and osteogenesis differentiation of HUMSCs. At 12th weeks, more micro-vessels and new bone were formed around the composite scaffolds compared with other groups, the defect was almost repaired.
Conclusion:
Our study for the first time identified that the combination of PRP gel, HUMSCs and nHA-PA66 scaffold could significantly promote angiogenesis and bone regeneration in rat LBD, which may have implications for its further application in clinical LBD treatment.
Similar content being viewed by others
References
Vidal L, Kampleitner C, Brennan MÁ, Hoornaert A, Layrolle P. Reconstruction of large skeletal defects: current clinical therapeutic strategies and future directions using 3D printing. Front Bioeng Biotechnol. 2020;8:61.
Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury. 2011;42:S3-15.
Berner A, Reichert JC, Müller MB, Zellner J, Pfeifer C, Dienstknecht T, et al. Treatment of long bone defects and non-unions: from research to clinical practice. Cell Tissue Res. 2012;347:501–19.
Zhang LY, Bi Q, Zhao C, Chen JY, Cai MH, Chen XY. Recent advances in biomaterials for the treatment of bone defects. Organogenesis. 2020;16:113–25.
Cui Y, Zhu T, Li A, Liu B, Cui Z, Qiao Y, et al. Porous particle-reinforced bioactive gelatin scaffold for large segmental bone defect repairing. ACS Appl Mater Interfaces. 2018;10:6956–64.
Toosi S, Behravan N, Behravan J. Nonunion fractures, mesenchymal stem cells and bone tissue engineering. J Biomed Mater Res A. 2018;106:2552–62.
Kangari P, Talaei-Khozani T, Razeghian-Jahromi I, Razmkhah M. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem Cell Res Ther. 2020;11:492.
Wen Y, Gu W, Cui J, Yu M, Zhang Y, Tang C, et al. Platelet-rich plasma enhanced umbilical cord mesenchymal stem cells-based bone tissue regeneration. Arch Oral Biol. 2014;59:1146–54.
Zhang Y, Deng X, Jiang D, Luo X, Tang K, Zhao Z, et al. Long-term results of anterior cervical corpectomy and fusion with nano-hydroxyapatite/polyamide 66 strut for cervical spondylotic myelopathy. Sci Rep. 2016;6:26751.
Hu B, Wang L, Song Y, Hu Y, Lyu Q, Liu L, et al. A comparison of long-term outcomes of nanohydroxyapatite/polyamide-66 cage and titanium mesh cage in anterior cervical corpectomy and fusion: A clinical follow-up study of least 8 years. Clin Neurol Neurosurg. 2019;176:25–9.
Wang X, Ju F, Li A, Geng S, Sun J, Liu R, et al. Nell-1 gene modified mesenchymal stem cells on biomimetic porous nano-hydroxyapatite/polyamide 66 scaffolds effectively prevent nonunion in rats. J Biomat Tissue Eng. 2016;6:408–16.
Fan H, Zeng X, Wang X, Zhu R, Pei G. Efficacy of prevascularization for segmental bone defect repair using β-tricalcium phosphate scaffold in rhesus monkey. Biomaterials. 2014;35:7407–15.
Meheux CJ, McCulloch PC, Lintner DM, Varner KE, Harris JD. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy. 2016;32:495–505.
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638–46.
Xie H, Cao L, Ye L, Du J, Shan G, Hu J, et al. Autogenous bone particles combined with platelet-rich plasma can stimulate bone regeneration in rabbits. Exp Ther Med. 2020;20:279.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18:e3000410.
Wang H, Li Y, Zuo Y, Li J, Ma S, Cheng L. Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering. Biomaterials. 2007;28:3338–48.
Tajima N, Sotome S, Marukawa E, Omura K, Shinomiya K. A three-dimensional cell-loading system using autologous plasma loaded into a porous β-tricalcium-phosphate block promotes bone formation at extraskeletal sites in rats. Mater Sci Eng, C. 2007;27:625–32.
Qi XN, Mou ZL, Zhang J, Zhang ZQ. Preparation of chitosan/silk fibroin/hydroxyapatite porous scaffold and its characteristics in comparison to bi-component scaffolds. J Biomed Mater Res A. 2014;102:366–72.
Chen S, Xu J, Wei Q, Zhao Z, Chen X, Cui H, et al. VEGF/Flk1 mechanism is involved in roxarsone promotion of rat endothelial cell growth and B16F10 xenograft tumor angiogenesis. Sci Rep. 2019;9:17417.
Henrich D, Seebach C, Nau C, Basan S, Relja B, Wilhelm K, et al. Establishment and characterization of the Masquelet induced membrane technique in a rat femur critical-sized defect model. J Tissue Eng Regen Med. 2016;10:E382–96.
Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res. 1986;205:299–308.
Wang C, Lu WW, Wang M. Multifunctional fibrous scaffolds for bone regeneration with enhanced vascularization. J Mater Chem B. 2020;8:636–47.
Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010;3:248–69.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Acute leukemia working party of European blood and marrow transplant group: Eurocord-Netcord registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.
Bougioukli S, Saitta B, Sugiyama O, Tang AH, Elphingstone J, Evseenko D, et al. Lentiviral gene therapy for bone repair using human umbilical cord blood-derived mesenchymal stem cells. Hum Gene Ther. 2019;30:906–17.
Liu G, Li Y, Sun J, Zhou H, Zhang W, Cui L, et al. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A. 2010;16:971–82.
Cui L, Bao H, Liu Z, Man X, Liu H, Hou Y, et al. HUMSCs regulate the differentiation of ovarian stromal cells via TGF-β1/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats. Stem Cell Res Ther. 2020;11:386.
Qi Y, Niu L, Zhao T, Shi Z, Di T, Feng G, et al. Combining mesenchymal stem cell sheets with platelet-rich plasma gel/calcium phosphate particles: a novel strategy to promote bone regeneration. Stem Cell Res Ther. 2015;6:256.
Xu P, Wu Y, Zhou L, Yang Z, Zhang X, Hu X, et al. Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization. Burns Trauma. 2020;8:tkaa028.
Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21:7794.
Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34:665–71.
Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–96.
Ishida K, Kuroda R, Miwa M, Tabata Y, Hokugo A, Kawamoto T, et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng. 2007;13:1103–12.
Colciago A, Celotti F, Casati L, Giancola R, Castano SM, Antonini G, et al. In Vitro Effects of PDGF Isoforms (AA, BB, AB and CC) on migration and proliferation of SaOS-2 osteoblasts and on migration of human osteoblasts. Int J Biomed Sci. 2009;5:380–9.
Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205:228–36.
Hu K, Olsen BR. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest. 2016;126:509–26.
Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, et al. TGF-beta1 induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15:757–65.
Glueck M, Gardner O, Czekanska E, Alini M, Stoddart MJ, Salzmann GM, et al. Induction of osteogenic differentiation in human mesenchymal stem cells by crosstalk with osteoblasts. Biores Open Access. 2015;4:121–30.
Tsao YT, Huang YJ, Wu HH, Liu YA, Liu YS, Lee OK. Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells. Int J Mol Sci. 2017;18:159.
Wang L, Li ZY, Wang YP, Wu ZH, Yu B. Dynamic expression profiles of marker genes in osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Chin Med Sci J. 2015;30:108–13.
Sadeghinia A, Davaran S, Salehi R, Jamalpoor Z. Nano-hydroxy apatite/chitosan/gelatin scaffolds enriched by a combination of platelet-rich plasma and fibrin glue enhance proliferation and differentiation of seeded human dental pulp stem cells. Biomed Pharmacother. 2019;109:1924–31.
Kawamura K, Yajima H, Ohgushi H, Tomita Y, Kobata Y, Shigematsu K, et al. Experimental study of vascularized tissue-engineered bone grafts. Plast Reconstr Surg. 2006;117:1471–9.
Acknowledgements
The authors wish to thank Professor Lei Yang from Harbin Medical University, China, for the technical help and helpful discussion. We also gratefully acknowledge the core facilities and software provided by the Orthopedic Diagnosis and Treatment Center of the First Affiliated Hospital of Harbin Medical University, China.
Funding
This work was funded by Heilongjiang Provincial Postdoctoral Science Foundation, China (No.LBH-Z18202).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests.
Ethical statement
The animal studies were performed after receiving approval of the Institutional Animal Care and Use Committee (IACUC) in Harbin Medical University (IACUC no. 2022061)
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Liu, W., Huang, Y., Liu, D. et al. The Combination of Platelet Rich Plasma Gel, Human Umbilical Mesenchymal Stem Cells and Nanohydroxyapatite/polyamide 66 Promotes Angiogenesis and Bone Regeneration in Large Bone Defect. Tissue Eng Regen Med 19, 1321–1336 (2022). https://doi.org/10.1007/s13770-022-00471-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-022-00471-3